http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006035286-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ed9bfe675714cd1e8279d2cbd0ee1c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cec07aa326bea7f63e3eb77c46e3df0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b105f6a41561aef39d06f29c8e94d987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bedd17ebf078837f5a62aab18e5dd02b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-24
filingDate 2005-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9c0bd59bac34a058149deab7bcaf12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a8843b7ed12b1c2236346667670eace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ed50307a543055a510ed01bd634eb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aa78b467c455546acb20ff21805d68d
publicationDate 2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006035286-A3
titleOfInvention Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof
abstract The present invention provides processes for preparing enantiomerically pure fluvastatin sodium. The present invention also provides pharmaceutical compositions comprising the enantiomerically pure fluvastatin sodium for antagonizing HMG-CoA. In addition the present invention provides a novel polymorphic form of enantiomerically pure fluvastatin sodium.
priorityDate 2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03064392-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5354772-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005063728-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23679527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9954640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9932627

Total number of triples: 38.